BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 186102)

  • 21. Adenosine-mediated stimulation of bone cell adenylate cyclase activity.
    Peck WA; Carpenter JG; Schuster RJ
    Endocrinology; 1976 Sep; 99(3):901-9. PubMed ID: 182472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic AMP accumulation in psoriatic skin: differential responses to histamine, AMP, and einephrine by the uninvolved and involved epidermis.
    Iizuka H; Adachi K; Halprin KM; Levine V
    J Invest Dermatol; 1978 May; 70(5):250-3. PubMed ID: 205616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine-induced cyclic AMP increase in pig lymphocytes is not related to adenylate cyclase stimulation.
    Bonnafous JC; Dornand J; Mani JC
    Biochim Biophys Acta; 1979 Oct; 587(2):180-91. PubMed ID: 226170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal adenylate cyclase: stimulation of the histamine (H2) receptor by tolazoline.
    Iizuka H; Adachi K; Halprin KM; Levine V
    J Invest Dermatol; 1977 Nov; 69(5):442-45. PubMed ID: 198480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pharmacological agents on human keratinocyte mitosis in vitro. I. Inhibition by adenine nucleotides.
    Harper RA; Flaxman BA; Chopra DP
    Proc Soc Exp Biol Med; 1974 Sep; 146(4):1032-6. PubMed ID: 4370775
    [No Abstract]   [Full Text] [Related]  

  • 26. Bradykinin-dependent activation of adenylate cyclase activity and cyclic AMP accumulation in tracheal smooth muscle occurs via protein kinase C-dependent and -independent pathways.
    Stevens PA; Pyne S; Grady M; Pyne NJ
    Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):233-9. PubMed ID: 8280104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylated adenosine derivatives as low-affinity adenosine-receptor agonists. Methodological implications for the adenylate cyclase assay.
    Schütz W; Steurer G; Tuisl E; Plass H
    Biochem J; 1984 May; 220(1):207-12. PubMed ID: 6331407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of pig epidermal adenylate-cyclase responses by protein-synthesis inhibitors: its relation to glucocorticoid and colchicine effects.
    Iizuka H; Kishiyama K; Ohkuma N; Ohkawara A
    Arch Dermatol Res; 1985; 277(6):466-72. PubMed ID: 4051556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The experimental study of the effect of cyclosporin A on epidermis].
    Kato N
    Hokkaido Igaku Zasshi; 1989 Mar; 64(2):110-8. PubMed ID: 2471681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal adenylate cyclase systems: the retention of hormone responsiveness after enzymatic separation of pure epidermis.
    Uzuka M; Adachi K; Iizuka H; Halprin KM; Levine V
    J Invest Dermatol; 1977 Aug; 69(2):194-7. PubMed ID: 196027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of adenylate cyclase and cyclic AMP phosphodiesterase by 5-hydroxytryptamine and calcium ions in blowfly salivary-gland homogenates.
    Litosch I; Fradin M; Kasaian M; Lee HS; Fain JN
    Biochem J; 1982 Apr; 204(1):153-9. PubMed ID: 6288011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of adenylate cyclase and cyclic nucleotide phosphodiesterase in hamster isolated capillary preparations.
    Nemecek GM
    Biochim Biophys Acta; 1980 Mar; 628(2):125-35. PubMed ID: 6244001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
    Barber AJ
    Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic GMP system in the epidermis.
    Adachi K; Aoyagi T; Iizuka H; Halprin KM; Levin V
    Curr Probl Dermatol; 1980; 10():39-65. PubMed ID: 6263550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epinephrine activation of pig skin adenylate cyclase in vivo and subsequent refractoriness to activation.
    Iizuka H; Adachi K; Halprin KM; Levine V
    J Invest Dermatol; 1978 Mar; 70(3):119-22. PubMed ID: 204708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultraviolet radiation augments epidermal beta-adrenergic adenylate cyclase response.
    Iizuka H; Kajita S; Ohkawara A
    J Invest Dermatol; 1985 May; 84(5):401-3. PubMed ID: 2987360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of in vitro PUVA treatment on adenylate cyclase responses of epidermis.
    Kajita S; Iizuka H
    J Dermatol; 1987 Apr; 14(2):132-6. PubMed ID: 2440931
    [No Abstract]   [Full Text] [Related]  

  • 39. Colchicine-induced alteration of hormone-stimulated cyclic AMP synthesis in pig skin (epidermis).
    Iizuka H; Kishiyama K; Ohkuma N; Murata H; Ohkawara A
    J Invest Dermatol; 1984 Apr; 82(4):357-61. PubMed ID: 6323587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraneuronal guanylyl-imidodiphosphate injection mimics long-term synaptic hyperpolarization in Aplysia.
    Treistman SN; Levitan IB
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4689-92. PubMed ID: 188052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.